Nordea Investment Management Ab Novavax Inc Transaction History

Nordea Investment Management Ab

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$36.28 - $75.29 $145,120 - $301,160	-4,000 Closed	0 $0
Q3 2021 Nov 01, 2021	SELL	$177.8 - $270.58 $711,200 - $1.08 Million	-4,000 Reduced 50.0%	4,000 $810,000
Q3 2021 Nov 01, 2021	BUY	$177.8 - $270.58 $711,200 - $1.08 Million	4,000 Added 100.0%	8,000 $1.66 Million
Q2 2021 Jul 16, 2021	SELL	$121.0 - $257.67 $6.66 Million - $14.2 Million	-55,023 Reduced 93.22%	4,000 $849,000
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $25,985 - $73,583	-230 Reduced 0.39%	59,023 $10.6 Million
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $4.67 Million - $8.27 Million	59,253 New	59,253 $6.61 Million

284

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $731M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

Stay updated on Nordea Investment Management Ab with notifications on news.